Nuclear Magnetic Resonance Imaging of Tumor Hypoxia
肿瘤缺氧的核磁共振成像
基本信息
- 批准号:7102436
- 负责人:
- 金额:$ 20.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-01 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Treatment strategies are stratified by risk factors; a goal of stratification into different prognostic groups is to
design risk based treatment strategies. Long term survival is determined by "risk factors" that predict
prognostic parameters such as probability of local control and risk of developing systemic or metastatic
disease. Tumor hypoxia is predictive of both risk of metastases and aggressive local disease. A
non-invasive assay to measure hypoxia would provide prognostic information regarding local tumor
aggressiveness and metastatic risk for development of risk based therapy, and for monitoring changes in
oxygenation with treatment, could impact further therapy. The central hypothesis of this proposal is that
tumor hypoxia and changes in oxygenation can be evaluated non-invasively using selected surrogate
"markers". In all studies, we will utilize a stereotaxic template we have developed to register both the in
vivo data and the p02 and pimonidazole studies. In Aim 1 we will test and validate a novel derivative of
misonidazole (trifluoromisonidazole (T19F-FMISO)) for imaging hypoxia. We will determine the optimal
dose as a balance between signal to noise requirements vs. specificity for imaging hypoxia, and also
compare to 18F-misonidazole and p02. In Aim 2 we will evaluate quantitation of lactate, dynamic contrast
enhanced MRI, andT19F-FMISO as oxygen surrogates and validate them against p02 and pimonidazole.
In Aim 2B, we will study changes in hypoxia induced by anti-neoplastic therapy and use these
measurements as potential surrogate and compare to p02, microvessel density and radiobiological assays.
The goal of Aim 2 is to determine which is the best surrogate of hypoxia and apply this in Aim 3. Aim 3 will
use this data to optimize hypoxia driven suicide gene therapy. In aim 3, we will develop a fusion suicide
gene (Cytosine Deaminase - Uracil Phosphoribosyl Transferase - CD-UPRT), under the control of a
hypoxia response element (HRE) which can be quantitatively imaged by 19F NMR chemical shift imaging.
We will develop this system as a both a reporter and suicide therapy system and evaluate its efficacy and
compare it with thymidine kinase in parallel studies.
治疗策略按风险因素分层;分层到不同预后组的目标是
设计基于风险的治疗策略。长期生存是由“风险因素”决定的,
预后参数,如局部控制的可能性和发生系统性或转移性疾病的风险
疾病肿瘤缺氧可预测转移和侵袭性局部疾病的风险。一
测量缺氧的非侵入性测定将提供关于局部肿瘤的预后信息
侵袭性和转移风险,用于开发基于风险的治疗,并用于监测
氧合治疗可能影响进一步治疗。这一提议的核心假设是,
肿瘤缺氧和氧合变化可以使用选择的替代物非侵入性地评估
“标记”。在所有的研究中,我们将利用我们开发的立体定位模板来记录两个在
体内数据和P02和哌莫硝唑研究。在目标1中,我们将测试和验证一种新的衍生物,
米索硝唑(三氟米索硝唑(T19 F-FMISO))用于缺氧成像。我们将确定最佳的
剂量作为信噪比要求与成像缺氧特异性之间的平衡,以及
与18F-米索硝唑和p02相比。在目标2中,我们将评估乳酸定量、动态对比度
增强MRI和T19 F-FMISO作为氧替代物,并验证它们对p02和pimonidazole的作用。
在目标2B中,我们将研究抗肿瘤治疗诱导的缺氧变化,并使用这些变化。
测量值作为潜在的替代物,并与P02、微血管密度和放射生物学测定进行比较。
目标2的目标是确定哪一个是缺氧的最佳替代物,并将其应用于目标3。目标3将
使用这些数据来优化缺氧驱动的自杀基因治疗。在目标3中,我们将开发一种聚变自杀
基因(胞嘧啶脱氨酶-尿嘧啶磷酸核糖转移酶- CD-UPRT),在一个
缺氧反应元件(HRE),其可以通过19 F NMR化学位移成像定量成像。
我们将开发这个系统作为一个报告和自杀治疗系统,并评估其疗效,
在平行研究中将其与胸苷激酶进行比较。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JASON Arthur KOUTCHER其他文献
JASON Arthur KOUTCHER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JASON Arthur KOUTCHER', 18)}}的其他基金
Imaging tumor and T cell responses to metabolic and immune modulation therapy
成像肿瘤和 T 细胞对代谢和免疫调节治疗的反应
- 批准号:
10192675 - 财政年份:2017
- 资助金额:
$ 20.32万 - 项目类别:
Project 2: Early Detection of Breast Cancer Subtypes by Raman Spectroscopy with Heavy Water Labeling and MultiPhoton Microscopy
项目2:通过重水标记拉曼光谱和多光子显微镜早期检测乳腺癌亚型
- 批准号:
10250468 - 财政年份:2008
- 资助金额:
$ 20.32万 - 项目类别:
Project 2: Early Detection of Breast Cancer Subtypes by Raman Spectroscopy with Heavy Water Labeling and MultiPhoton Microscopy
项目2:通过重水标记拉曼光谱和多光子显微镜早期检测乳腺癌亚型
- 批准号:
10021578 - 财政年份:2008
- 资助金额:
$ 20.32万 - 项目类别:
Non-Invasive Markers of Tumor Response: A Study of Anti-Angiogenic Therapy
肿瘤反应的非侵入性标志物:抗血管生成治疗的研究
- 批准号:
7729463 - 财政年份:2008
- 资助金额:
$ 20.32万 - 项目类别:
Optimizing Chemotherapy Dose Using 31P NMR Spectroscopy
使用 31P NMR 波谱优化化疗剂量
- 批准号:
7013706 - 财政年份:2005
- 资助金额:
$ 20.32万 - 项目类别:
Optimizing Chemotherapy Dose Using 31P NMR Spectroscopy
使用 31P NMR 波谱优化化疗剂量
- 批准号:
7140177 - 财政年份:2005
- 资助金额:
$ 20.32万 - 项目类别:
相似海外基金
CAREER: Safe Continuum Robot Inside Magnetic Resonance Imaging (MRI)
职业:磁共振成像 (MRI) 内的安全连续体机器人
- 批准号:
2339202 - 财政年份:2024
- 资助金额:
$ 20.32万 - 项目类别:
Standard Grant
Magnetic resonance imaging studies of catalytic monoliths
催化整体的磁共振成像研究
- 批准号:
2905857 - 财政年份:2024
- 资助金额:
$ 20.32万 - 项目类别:
Studentship
Establishment of human abdominal aortic aneurysm wall strength prediction model using Ex Vivo Superparamagnetic Iron Oxide–Enhanced Magnetic Resonance Imaging
利用Ex Vivo超顺磁性氧化铁建立人体腹主动脉瘤壁强度预测模型
- 批准号:
23K08226 - 财政年份:2023
- 资助金额:
$ 20.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Magnetic Resonance Imaging (MRI) and Artificial Intelligence (AI) can improve preoperative malignancy risk prediction of ovarian masses.
磁共振成像(MRI)和人工智能(AI)可以改善卵巢肿块的术前恶性肿瘤风险预测。
- 批准号:
486885 - 财政年份:2023
- 资助金额:
$ 20.32万 - 项目类别:
Operating Grants
Comparison of direct and indirect magnetic resonance imaging of myelin in Alzheimer's disease
阿尔茨海默病髓磷脂直接和间接磁共振成像的比较
- 批准号:
10680319 - 财政年份:2023
- 资助金额:
$ 20.32万 - 项目类别:
Perfluoroalkyl substances and non-alcoholic fatty liver disease in children: Leveraging magnetic resonance imaging to unravel potential mechanisms and exposure mixture effects
全氟烷基物质与儿童非酒精性脂肪肝:利用磁共振成像揭示潜在机制和暴露混合物效应
- 批准号:
10646759 - 财政年份:2023
- 资助金额:
$ 20.32万 - 项目类别:
SBIR Phase I: Novel development of a pediatric Magnetic Resonance Imaging (MRI) scanner
SBIR 第一阶段:儿科磁共振成像 (MRI) 扫描仪的新开发
- 批准号:
2323231 - 财政年份:2023
- 资助金额:
$ 20.32万 - 项目类别:
Standard Grant
Functional Magnetic Resonance Imaging and Deep Learning to Improve Deep Brain Stimulation Therapy
功能磁共振成像和深度学习改善脑深部刺激疗法
- 批准号:
10717563 - 财政年份:2023
- 资助金额:
$ 20.32万 - 项目类别:
Fat quantification using whole-body magnetic resonance imaging (WB-MRI) in malignant bone disease
使用全身磁共振成像 (WB-MRI) 进行脂肪定量在恶性骨疾病中的应用
- 批准号:
2886467 - 财政年份:2023
- 资助金额:
$ 20.32万 - 项目类别:
Studentship
Use of advanced magnetic resonance imaging and positron emission tomography for characterising inflammation in brain tumours
使用先进的磁共振成像和正电子发射断层扫描来表征脑肿瘤的炎症
- 批准号:
2897371 - 财政年份:2023
- 资助金额:
$ 20.32万 - 项目类别:
Studentship